Evidence map›Paper›PMID 38526341›Full record

ArticleThe Journal of infectious diseases2024

Development and Validation of Multiplex Assays for Mouse and Human IgG and IgA to Neisseria gonorrhoeae Antigens.

Erica L Stover, Marguerite B Little, Kristie L Connolly, Lixin Li, Robert A Nicholas, Aleksandra E Sikora, Ann E Jerse, Marcia M Hobbs, J Alex Duncan, Andrew N Macintyre

Abstract readValidation Study
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erica L StoverDuke Human Vaccine Institute, Department of Medicine, School of Medicine, Duke University, Durham, North Carolina.
Marguerite B LittleDepartment of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Kristie L ConnollyDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland.
Lixin LiDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon.
Robert A NicholasDepartment of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Aleksandra E SikoraDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon.
Ann E JerseDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland.
Marcia M HobbsDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
J Alex DuncanDepartment of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Andrew N MacintyreDuke Human Vaccine Institute, Department of Medicine, School of Medicine, Duke University, Durham, North Carolina.ORCID 0000-0002-5297-0207

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational and Clinical Sciences Institute (NC TraCS)UM1TR004406 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS J SHAHEEN · 2023 to 2026
$37.5M
Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
The Gonorrhea Vaccine Cooperative Research CenterU19AI144180 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MACINTYRE, ANDREW · 2019 to 2023
$10.7M
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (ACU19AI113170 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI JERSE, ANN E. · 2014 to 2018
$6.9M
Proteomics-Driven Reverse Vaccinology for GonorrheaR01AI117235 · NIAID · OREGON STATE UNIVERSITY · PI Aleksandra Elzbieta Sikora · 2015 to 2026
$6.7M
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.U01AI162457 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2021 to 2025
$3.9M
Experimental human infection with isogenic mutants of Neisseria gonorrhoeaeU01AI114378 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOBBS, MARCIA METZGAR · 2015 to 2019
$2.8M
NCATS NIH HHS UL1 TR002489NCATS NIH HHS UL1 TR002553NCATS NIH HHS UM1 TR004406NIAID NIH HHS R01 AI117235NIAID NIH HHS U01 AI114378NIAID NIH HHS U01 AI162457NIAID NIH HHS U19 AI144180NIAID NIH HHS UC6 AI058607NIH HHS U01-AI114378
6 · The paper itself

Abstract

There is an urgent need for vaccines against Neisseria gonorrhoeae, the causative agent of gonorrhea. Vaccination with an outer membrane vesicle-based Neisseria meningitidis vaccine provides some protection from N. gonorrhoeae; however, the mechanisms underlying this cross-protection are unknown. To address this need, we developed multiplexed bead-based assays for the relative quantification of human and mouse IgG and IgA against N gonorrhoeae antigens. The assays were evaluated for analyte independence, dilutional linearity, specificity, sensitivity, intra- and interassay variability, and robustness to sample storage conditions. The assay was then used to test samples from mice and humans immunized with an N meningitidis outer membrane vesicle vaccine.

Indexed as

Antibodies, BacterialAntigens, BacterialGonorrheaImmunoglobulin AImmunoglobulin GNeisseria gonorrhoeaeAnimalsFemaleHumansMiceReproducibility of ResultsSensitivity and SpecificityAntibodies, BacterialAntigens, BacterialImmunoglobulin AImmunoglobulin G4CMenBassay developmenthumoral response monitoringmultiplex bead assayNeisseria gonorrhoeae

Identifiers

PMID38526341
PMCPMC11481346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.